112 related articles for article (PubMed ID: 17477425)
1. Administration of dendritic cells modified by RNA interference prolongs cardiac allograft survival.
Xiang J; Gu X; Zhou Y; Gong X; Qian S; Chen Z
Microsurgery; 2007; 27(4):320-3. PubMed ID: 17477425
[TBL] [Abstract][Full Text] [Related]
2. Graded function of CD80 and CD86 in initiation of T-cell immune response and cardiac allograft survival.
Xiang J; Gu X; Qian S; Chen Z
Transpl Int; 2008 Feb; 21(2):163-8. PubMed ID: 17971032
[TBL] [Abstract][Full Text] [Related]
3. Application of recipient-derived dendritic cells to induce donor-specific T-cell hyporesponsiveness.
Tiao MM; Lu L; Tao R; Harnaha J; Fung JJ; Huang LT; Qian S
Transplant Proc; 2004 Jun; 36(5):1592-4. PubMed ID: 15251391
[TBL] [Abstract][Full Text] [Related]
4. TGF-beta(1) gene modified immature dendritic cells exhibit enhanced tolerogenicity but induce allograft fibrosis in vivo.
Sun W; Wang Q; Zhang L; Pan J; Zhang M; Lu G; Yao H; Wang J; Cao X
J Mol Med (Berl); 2002 Aug; 80(8):514-23. PubMed ID: 12185452
[TBL] [Abstract][Full Text] [Related]
5. Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival.
Liang X; Lu L; Chen Z; Vickers T; Zhang H; Fung JJ; Qian S
Transplantation; 2003 Aug; 76(4):721-9. PubMed ID: 12973117
[TBL] [Abstract][Full Text] [Related]
6. Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection.
Zhang X; Li M; Lian D; Zheng X; Zhang ZX; Ichim TE; Xia X; Huang X; Vladau C; Suzuki M; Garcia B; Jevnikar AM; Min WP
Clin Immunol; 2008 Jun; 127(3):313-21. PubMed ID: 18358783
[TBL] [Abstract][Full Text] [Related]
7. [Pretreatment of donor dendritic cells with NBD-peptide prolongs mouse cardiac allograft survival].
Su G; Zhao WZ; Chen JJ; Xu J; Qiao CH; Liu C; Sun ZQ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1562-7. PubMed ID: 18819868
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic insights into achievement of cardiac allograft long-term survival by treatment with immature dendritic cells and sub-dose sirolimus.
Tao R; Wang L; Chen CH; Wang SH; Demarco RA; Lotze MT; Thai NL; Fung JJ; Lu L; Qian S
J Heart Lung Transplant; 2006 Mar; 25(3):310-9. PubMed ID: 16507425
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive and trafficking properties of donor splenic and bone marrow dendritic cells.
Emmanouilidis N; Guo Z; Dong Y; Newton-West M; Adams AB; Lee ED; Wang J; Pearson TC; Larsen CP; Newell KA
Transplantation; 2006 Feb; 81(3):455-62. PubMed ID: 16477234
[TBL] [Abstract][Full Text] [Related]
10. Long-term survival of limb allografts induced by pharmacologically conditioned, donor alloantigen-pulsed dendritic cells without maintenance immunosuppression.
Ikeguchi R; Sacks JM; Unadkat JV; Solari M; Horibe EK; Thomson AW; Lee AW; Feili-Hariri M
Transplantation; 2008 Jan; 85(2):237-46. PubMed ID: 18212629
[TBL] [Abstract][Full Text] [Related]
11. Prolongation of cardiac allograft survival by systemic administration of immature recipient dendritic cells deficient in NF-kappaB activity.
Tiao MM; Lu L; Tao R; Wang L; Fung JJ; Qian S
Ann Surg; 2005 Mar; 241(3):497-505. PubMed ID: 15729074
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine 1-phosphate receptor agonism impairs skin dendritic cell migration and homing to secondary lymphoid tissue: association with prolonged allograft survival.
Lan YY; Tokita D; Wang Z; Wang HC; Zhan J; Brinkmann V; Thomson AW
Transpl Immunol; 2008 Nov; 20(1-2):88-94. PubMed ID: 18694829
[TBL] [Abstract][Full Text] [Related]
13. Free bone graft attenuates acute rejection and in combination with cyclosporin a leads to indefinite cardiac allograft survival.
Wang H; Ge W; Arp J; Zassoko R; Liu W; Ichim TE; Jiang J; Jevnikar AM; Garcia B
J Immunol; 2009 May; 182(10):5970-81. PubMed ID: 19414748
[TBL] [Abstract][Full Text] [Related]
14. Promotion of long-term heart allograft survival by combination of mobilized donor plasmacytoid dendritic cells and anti-CD154 monoclonal antibody.
Björck P; Coates PT; Wang Z; Duncan FJ; Thomson AW
J Heart Lung Transplant; 2005 Aug; 24(8):1118-20. PubMed ID: 16102450
[TBL] [Abstract][Full Text] [Related]
15. Induction of donor-specific T-cell hyporesponsiveness using dexamethasone-treated dendritic cells in two fully mismatched rat kidney transplantation models.
Stax AM; Gelderman KA; Schlagwein N; Essers MC; Kamerling SW; Woltman AM; van Kooten C
Transplantation; 2008 Nov; 86(9):1275-82. PubMed ID: 19005410
[TBL] [Abstract][Full Text] [Related]
16. Effects of RNA interference on CD80 and CD86 expression in bone marrow-derived murine dendritic cells.
Gu X; Xiang J; Yao Y; Chen Z
Scand J Immunol; 2006 Dec; 64(6):588-94. PubMed ID: 17083614
[TBL] [Abstract][Full Text] [Related]
17. Administration of tolerogenic dendritic cells induced by interleukin-10 prolongs rat splenic allograft survival.
Jiang H; Hou L; Qiao H; Pan S; Zhou B; Liu C; Sun X
Transplant Proc; 2004 Dec; 36(10):3255-9. PubMed ID: 15686741
[TBL] [Abstract][Full Text] [Related]
18. Murine bone marrow mesenchymal stem cells cause mature dendritic cells to promote T-cell tolerance.
Wang Q; Sun B; Wang D; Ji Y; Kong Q; Wang G; Wang J; Zhao W; Jin L; Li H
Scand J Immunol; 2008 Dec; 68(6):607-15. PubMed ID: 18959624
[TBL] [Abstract][Full Text] [Related]
19. Effect of immature dendritic cell injection before heterotropic cardiac allograft.
Oh BC; Lee HM; Lim DP; Cho JJ; Lee G; Lee DS; Lee JR
Transplant Proc; 2006 Dec; 38(10):3189-92. PubMed ID: 17175218
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cells activated by lipopolysaccharide after dexamethasone treatment induce donor-specific allograft hyporesponsiveness.
Emmer PM; van der Vlag J; Adema GJ; Hilbrands LB
Transplantation; 2006 May; 81(10):1451-9. PubMed ID: 16732184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
